What’s Behind the Surge in Pharmaceutical Deals?

Aug. 25 (Bloomberg) –- Bloomberg’s Shannon Pettypiece discusses Roche’s $8.3 billion offer for InterMune and big pharmaceutical deals. She speaks on “Bottom Line.” (Source: Bloomberg)

Ecognosis' Freris: Nothing Tells Me to Buy China
39:45 - Andrew Freris, chief executive officer at Ecognosis Advisory, discusses the Hong Kong Market, liquidity in the Chinese markets and U.S.-China relations. He speaks to Bloomberg's Shery Ahn on "Bloomberg Markets." (Source: Bloomberg)
  • Making the Case for Emerging Market Assets
  • Singapore's Housing Slump May Get Some Relief
  • Cathay Seeks New Path With Job Cuts and Revamp